Dry powder inhalers: physicochemical and aerosolization properties of several size-fractions of a promising alterative carrier, freeze-dried mannitol.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
MetadataShow full item record
AbstractThe purpose of this work was to evaluate the physicochemical and inhalation characteristics of different size fractions of a promising carrier, i.e., freeze-dried mannitol (FDM). FDM was prepared and sieved into four size fractions. FDMs were then characterized in terms of micromeritic, solid-state and bulk properties. Dry powder inhaler (DPI) formulations were prepared using salbutamol sulphate (SS) and then evaluated in terms of drug content homogeneity and in vitro aerosolization performance. The results showed that the crystalline state of mannitol was maintained following freeze-drying for all size fractions of FDM. All FDM particles showed elongated morphology and contained mixtures of α-, β- and δ-mannitol. In comparison to small FDM particles, FDMs with larger particle sizes demonstrated narrower size distributions, higher bulk and tap densities, lower porosities and better flowability. Regardless of particle size, all FDMs generated a significantly higher (2.2-2.9-fold increase) fine particle fraction (FPF, 37.5 ± 0.9%-48.6 ± 2.8%) of SS in comparison to commercial mannitol. The FPFs of SS were related to the shape descriptors of FDM particles; however, FPFs did not prove quantitative apparent relationships with either particle size or powder bulk descriptors. Large FDM particles were more favourable than smaller particles because they produced DPI formulations with better flowability, better drug content homogeneity, lower amounts of the drug depositing on the throat and contained lower fine-particle-mannitol. Optimized stable DPI formulations with superior physicochemical and pharmaceutical properties can be achieved using larger particles of freeze-dried mannitol (FDM).
CitationDry powder inhalers: physicochemical and aerosolization properties of several size-fractions of a promising alterative carrier, freeze-dried mannitol. 2015, 68:56-67 Eur J Pharm Sci
JournalEuropean journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
- Freeze-dried mannitol for superior pulmonary drug delivery via dry powder inhaler.
- Authors: Kaialy W, Nokhodchi A
- Issue date: 2013 Feb
- Effect of carrier particle shape on dry powder inhaler performance.
- Authors: Kaialy W, Alhalaweh A, Velaga SP, Nokhodchi A
- Issue date: 2011 Dec 12
- Towards a more desirable dry powder inhaler formulation: large spray-dried mannitol microspheres outperform small microspheres.
- Authors: Kaialy W, Hussain T, Alhalaweh A, Nokhodchi A
- Issue date: 2014 Jan
- Dry powder inhalers: mechanistic evaluation of lactose formulations containing salbutamol sulphate.
- Authors: Kaialy W, Ticehurst M, Nokhodchi A
- Issue date: 2012 Feb 28
- Effect of carrier morphology and surface characteristics on the development of respirable PLGA microcapsules for sustained-release pulmonary delivery of insulin.
- Authors: Hamishehkar H, Emami J, Najafabadi AR, Gilani K, Minaiyan M, Mahdavi H, Nokhodchi A
- Issue date: 2010 Apr 15